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Abstract OBJECTIVE: The aim of this study was to asses the influence of operative treat-
ment of leiomyomas on lipid profile. The study was conducted from April 1, 2000, 
through April 30, 2002 in The Department of Septic Gynecology and Obstetrics 
at Collegium Medicum of the Jagiellonian University. 
METHODOLOGY: Most hysterectomies are performed because of leiomyomas, 
which are the most common benign tumors of the female reproductive organ. 
Pathogenesis and evolution of uterine leiomyomas are not well understood. 
Treatment of leiomyomas is divided into operative and inoperative. Operative 
methods include generally laparoscopic myomectomy, conservative myomec-
tomy and hysterectomy. 130 women with diagnosed leiomyomas were analyzed 
in four groups. 
CONCLUSION : Regardless of the type of performed surgery, decrease in choles-
terol, HDL and LDL are observed 10 days after operation, with return to pre-
operative values at 6 months after surgical procedure. The highest level of cho-
lesterol and LDL (6 moths from surgery) is observed in patients who underwent 
hysterectomy with bilateral oophorectomy.
Introduction
Most hysterectomies are performed because 
of leiomyomas, which are the most common be-
nign tumors of the female reproductive organ [2]. 
The prevalence ranges from 25% to 30% after the 
age of 30 [2, 13, 14]. Pathogenesis and evolution 
of uterine leiomyomas are not well understood. 
Some investigators have suggested that residual 
undifferentiated cells in the myometrium are the 
progenitor cells of leiomyomas [2, 19]. Other au-
thors assume that acquired chromosomal aber-
rations play a pathogenetic role in uterine leio-
myomas [12, 13, 14, 18]. Uterine fibroids appear 
and enlarge during the reproductive years. This 
observation suggests that steroid hormones se-
creted by the ovaries are necessary for the con-
tinued growth of these tumors [2]. They may 
cause abnormal uterine bleeding, they are often 
associated with reproductive failure and are the 
most frequent indication for hysterectomy [2,14]. 
Approximately one third of women with uter-
ine fibroids have symptoms that may eventually 
require medical or surgical intervention. Treat-
ment of leiomyomas is divided into operative and 
inoperative. Operative methods include generally 
laparoscopic myomectomy, conservative myomec-
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tomy and hysterectomy. Hysterectomy with uni- or bi-
lateral oophorectomy can provoke premature meno-
pause. The classic symptom of menopause, the hot 
flash, is related to declining estrogen levels, and is re-
ported by 85% of menopausal American women [5, 9]. 
Other problems observed in this population include: 
irritability, fatigue, nervousness, insomnia, sweating, 
depression, and vaginal dryness [9]. There is also in-
creased risk of cardiovascular disease and stroke, re-
lated to lipids disturbances. According to S. Jedrze-
jczyk et al., increased levels of triglycerides and 
low-density lipoprotein (LDL) and decreased levels of 
high-density lipoproteins (HDL) are also recorded [8]. 
Only proper hormonal replacement therapy can pro-
tect against menopausal symptoms and complications. 
Results of several studies indicate that patients gen-
erally believe in effectiveness of hysterectomy, 91% – 
100% of women reported being glad that they had un-
dergone the surgery [2, 5, 17]. 
Subject: The aim of this study was to asses the in-
fluence of the operative treatment of leiomyomas on 
lipid profile.
Material and Methods
The study was conducted from April 1, 2000, 
through April 30, 2002 in The Department of Sep-
tic Gynecology and Obstetrics at Collegium Medicum 
of the Jagiellonian University. 130 women with diag-
nosed leiomyomas were studied in four groups. Pa-
tients were divided into four groups based on:
• age,
• parity,
• number and size of leiomyoma,
• macroscopic examination of ovaries during opera-
tion,
• contraindications for laparoscopic myomectomy.
The first group consisted of patients who under-
went hysterectomy with bilateral oophorectomy, the 
second one included those after hysterectomy with 
unilateral oophorectomy, the third one – those after 
hysterectomy without bilateral oophorectomy. The 
fourth group involved patients in whom the conserva-
tive variant of myomectomy was performed.
Exclusion criteria comprised all general dysfunc-
tions that can affect clinical and psychological tests:
• diabetes mellitus,
• thyroid and parathyroid dysfunction,
• psychiatric disorders,
• circulatory and heart disorders,
• liver and kidney disorders.
Demographic data collected included patient age, 
weight, parity, education and employment status.
Before surgery, gynecological bimanual examina-
tion, exfoliative cytology, transvaginal ultrasonogra-
phy and assessment of the Ca-125 antigen were per-
formed. Other factors examined included general 
symptoms before and blood loss during the operation.
All patients after hysterectomy with bilateral oo-
phorectomy received 10mg intra-muscle injection of 
oestradiolum valerianicum and underwent subse-
quent hormonal replacement therapy.
Data from the post-surgical period included: body 
temperature, antibiotics, complications within healing 
of the vagina (inflammation or abscess) and result of 
pathological examination of removed uterus and ova-
ries.
Total cholesterol, low-density lipoprotein (LDL), 
high-density lipoproteins (HDL) and triglycerides 
(TG) were measure before surgery and at 10 days, and 
6 months after operation.
Differences in demographic and biochemical data 
between the four groups were evaluated with c² test.
Results
One hundred and thirty patients were enrolled in 
the trial. Patients were distributed into four groups 
based on the type of surgery (Table 1).
The four groups were similar with respect to demo-
graphic variables, including weight, parity, education 
and employment status. The only difference referred 
to age: patients in Group I were older than the others 
(p<0.05).
As it appeared in patients’ medical history, the most 
common symptoms on admission were:
• 61 (46.9%) menometrorrhagia,
• 34 (26.2%) pain in the lower part of the abdomen,
• 18 (13.8%) bleeding not related to menstruation,
• 9 (7%) difficulties with urination,
• 5 (4%) sacral pain,
• 3 (2.3%) pressure effect, vesical tenesmus.
According to gynecological examination of the va-
gina, in 42 patients (32.3%) descends of the anterior 
and posterior wall of the vagina were recorded, and 32 
patients (24.6%) had vaginitis. No pathological lesions 
on the cervix were diagnosed in 80 cases (61.5%). Lac-
eration of the cervix was found in 21 patients (16.1%). 
As revealed in clinical evaluation of the uterus, 80 pa-
tients (61.5%) had regular enlargement of the uterus, 
while 34 subjects (26.1%) had irregular one.
Location of the leiomyomas were as follows:
• in 52 patients (40%) – on the anterior wall,
• in 36 patients (27.7%) – on the posterior wall,
• in 23 patients (17.7%) – both on the anterior and 
posterior wall,
• in 12 patients (9.2%) – inside the cornu of the 
uterus,
• in 7 patients (5.4%) – isthmo-cervical site.
Mean size of the leiomyomatic uterus in terms of 
pregnant uterus was the highest in Group I – 14.2 ges-
tational weeks.
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Blood loss during surgery in 96 patients (73.8%) re-
mained below 300ml; in 18 cases (13.8%) ranged from 
300ml to 400ml; in 8 subjects (6.1%) it ranged from 
400 to 500ml, and in 8 other cases (6.1%) reached 
500ml and more. In Group I, 67 patients (83.7%) were 
administered antibiotic treatment, versus 17 subjects 
(85%) in Group II, 7 subjects (46.6%) in Group III, and 
11 patients (73.3%) in Group IV.
No severe complications after operations were re-
corded, such as bleeding or infections.
According to pathological examinations, the major-
ity of patients – 90 subjects (69.2%) featured leiomy-
oma, 26 (20%) leiomyoma partim hyalinisans, and 14 
(10.7%) developed leiomyoma cellulare.
Gynecological follow-up visit 6 months from sur-
gery revealed
• 82 patients (63%) experiencing no pathological 
changes,
• 30 patients (23%) with moderate vaginitis,
• 14 patients (10.7%) with severe vaginitis,
• 2 patients (1.5%) complaining about pain in the 
lower part of the abdomen,
• 2 patients (1.5%) after conservative myomectomy 
still having menometrorrhagia.
Total cholesterol, TG, HDL and LDL were assessed 
from patient’s blood sample before surgery and at 10 
days, and 6 months after operation. On the basis of 
mean results of serum lipids (general population), 
decrease in total cholesterol, LDL and HDL was ob-
served at 10 days from surgery, with return to preop-
erative value at 6 months from surgery (Fig. 1). These 
differences were statistically significant (p<0.001). 
Different behaviour was recorded in the case of tri-
glycerides: higher level at 10 days from surgery with 
return to preoperative value after 6 months.
Within the groups analyzed, the same tendency was 
observed in serum lipids concentration (Table 2). Re-
gardless of the type of surgery performed, decrease in 
cholesterol, HDL and LDL was observed at 10 days af-
ter operation, with return to preoperative values at 6 
months after surgical procedure (Fig. 2, Fig. 4, Fig. 5). 
Different situation was observed in the case of TG 
(Fig. 3).
The highest level of total cholesterol and LDL (6 
moths after operation) was reported in patients who 
Table 1: Four groups of participants. 
Participants
General 
population 
N=130
Group  I hysterectomy 
with bilateral 
oophorectomy N=80
Group   II hysterectomy 
with unilateral 
oophorectomy N=20
Group  III hysterectomy 
without bilateral 
oophorectomy N=15
Group  IV conservative 
myomectomy 
N=15
age 45.1+/–5.2 49.2+/–3.85 42.34+/–2.23 39.8+/–3.9 38.4+/–4.87
range 26–58 34–58 35–47 29–43 26–45
Table 2: Lipids serum concentration during the trial.
Examination Before surgery
10 days 
from surgery
6 months 
from surgery
Statistical significance
GROUP I
Cholesterol (mM) 5.68 5.31 6.18 P<0.001
TG (mM) 1.46 1.92 1.56 P<0.001
HDL (mM) 1.51 1.19 1.69 P<0.001
LDL (mM) 3.58 3.19 3.88 P<0.001
GROUP II
Cholesterol (mM) 5.87 5.28 5.74 P<0.001
TG (mM) 1.51 1.86 1.56 P<0.05
HDL (mM) 1.63 1.14 1.65 P<0.001
LDL (mM) 3.59 3.27 3.32 P>0.05
GROUP III
Cholesterol (mM) 5.10 4.66 5.48 P<0.01
TG (mM) 1.29 1.56 1.01 P<0.001
HDL (mM) 1.37 1.20 1.75 P<0.001
LDL (mM) 3.05 2.84 3.29 P>0.05
GROUP IV
Cholesterol (mM) 5.52 4.90 5.13 P<0.01
TG (mM) 1.32 1.43 1.16 P>0.05
HDL (mM) 1.71 1.23 1.52 P<0.001
LDL (mM) 3.24 3.07 3.07 P>0.05
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Figure 1. Mean values of lipids in general population. 
Figure 2. Mean values of total cholesterol in four groups.
Figure 3. Mean values of TG in four groups.
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underwent hysterectomy with bilateral oophorectomy 
(Fig. 2, Fig. 5). Women in Groups I and II had the high-
est level of TG at 6 months after gynecological proce-
dure (Fig. 3). Patients who underwent hysterectomy 
without bilateral oophorectomy were reported the 
highest rate of HDL (Fig. 4).
Discussion
According to Farish E. et al. and Notelovitz M. et 
al., who investigated effects of bilateral oophorectomy 
on lipoprotein metabolism, decrease in total choles-
terol, LDL and HDL was reported at early stage after 
surgical procedure and returned to preoperative value 
at 6 months later – which was similar to our results 
[4]. Women’s lipids metabolism six years after surgery 
on account of uterine leiomyomas was assessed by Ka-
minski B. et al. They concluded that in younger women 
with partial oophorectomy no changes of lipid metab-
olism were found. In older women after hysterectomy 
with bilateral oophorectomy, a marked increase in 
LDL and decrease in HDL were observed, which pro-
mote development of atherosclerosis [11]. Changes of 
the lipid profile in the blood serum may be connected 
with hormonal homeostatic disturbances, decreased 
level of estrogens and rising level of gonadotropins – 
the early period after surgical ovariectomy is charac-
terized by decrease in concentration of 17b-estradiol 
and increase of atherogenic lipid parameters [7].
Goldman G. et al. tried to explain the effect of en-
dogenous estrogen on lipid and lipoprotein metabo-
lism in premenopausal and postmenopausal women. 
They claimed that no significant differences were 
found in the serum lipid and lipoprotein profile, before 
castration and 6 months later [6]. We cannot agree 
with their conclusion that the effect of endogenous es-
trogen on lipid metabolism is doubtful and should be 
further investigated. We also cannot accept the results 
of the trial carried out by Carranza-Lira S. et al., in 
which they observed that hysterectomy does not have 
a deleterious effect on hormone or lipid levels, nor on 
bone density [3].
Patients with estrogen deficiency – after hysterec-
tomy with bilateral or unilateral oophorectomy – had 
the highest level of total cholesterol and LDL 6 months 
from surgery. This supports the theory that estrogens 
Figure 4. Mean values of HDL in four groups. 
Figure 5. Mean values of LDL in four groups.
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have significant influence on lipid metabolism [10, 15]. 
All women after such surgery should undergo subse-
quent hormonal replacement therapy. In the study by 
Paganini-Hill A. et al., the aim was to assess the rela-
tionships of lipid and lipoprotein levels with hormone 
replacement therapy. They studied 292 patients and 
discovered that estrogens users (with and without pro-
gestin) had lower total cholesterol and LDL and higher 
HDL – which protects against coronary heart disease 
and stroke [16]. The effect of surgical menopause and 
subsequent estrogen replacement therapy was also in-
vestigated by Bruschi F. et al. Their findings suggest 
that surgical menopause induces improper changes in 
the lipid profile three months from surgery, and that 
estrogen replacement therapy soon reverses them [1].
Peters H. et al. claimed that total cholesterol, LDL 
and apolipoprotein B form primary cardiovascular risk 
factors affected by menopause [17]. According to the 
study by Sultan N. et al., decrease in estradiol level 
and the associated decrease in HDL-C, observed in 
postmenopausal women, may be responsible for the 
increased risk of coronary heart disease after meno-
pause [20]. Several short-term randomized or cross-
over studies have shown that adding a progesterone-
derived progestin to estrogen replacement therapy 
decreased the benefit of estrogen replacement therapy 
on the HDL level [5,9].
Conclusions: Regardless of the type of surgery per-
formed, decrease in cholesterol, HDL and LDL are re-
corded at 10 days after operation, with return to pre-
operative values at 6 months after surgical procedure.
The highest level of cholesterol and LDL (6 moths 
from surgery) is observed in patients who underwent 
hysterectomy with bilateral oophorectomy.
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